IQVIA HOLDINGS INC. Gain (Loss) on Derivative Instruments, Net, Pretax
IQVIA HOLDINGS INC. (IQV) reported Gain (Loss) on Derivative Instruments, Net, Pretax of $182.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDerivativeInstrumentsNetPretax · last filed 2014-02-13
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2013-12-31 was $120.00K, a 185.71% increase year-over-year.
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2013-09-30 was $57.00K.
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2013-06-30 was $6.00K, a 98.17% decline year-over-year.
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for the quarter ending 2013-03-31 was $11.00K, a 95.88% decline year-over-year.
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for fiscal 2013 was $182.00K.
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for fiscal 2012 was -$571.00K.
- IQVIA HOLDINGS INC. gain (loss) on derivative instruments, net, pretax for fiscal 2011 was -$205.00K.
| Period end | Gain (Loss) on Derivative Instruments, Net, Pretax 3 month | Gain (Loss) on Derivative Instruments, Net, Pretax 6 month | Gain (Loss) on Derivative Instruments, Net, Pretax 9 month | Gain (Loss) on Derivative Instruments, Net, Pretax 12 month |
|---|---|---|---|---|
| 2013-12-31 | $120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $177.00K derived: sum of 2 quarters · filed 2014-02-13 | $183.00K derived: sum of 3 quarters · filed 2014-02-13 | $182.00K 10-K · filed 2014-02-13 |
| 2013-09-30 | $57.00K 10-Q · filed 2013-10-31 | $63.00K derived: sum of 2 quarters · filed 2013-10-31 | $62.00K 10-Q · filed 2013-10-31 | $116.00K derived: sum of 4 quarters · filed 2014-02-13 |
| 2013-06-30 | $6.00K 10-Q · filed 2013-08-01 | -$5.00K 10-Q · filed 2013-08-01 | $59.00K derived: sum of 3 quarters · filed 2014-02-13 | $40.00K derived: sum of 4 quarters · filed 2014-02-13 |
| 2013-03-31 | $11.00K 10-Q · filed 2013-05-14 | $53.00K derived: sum of 2 quarters · filed 2014-02-13 | $34.00K derived: sum of 3 quarters · filed 2014-02-13 | $361.00K derived: sum of 4 quarters · filed 2014-02-13 |
| 2012-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $23.00K derived: sum of 2 quarters · filed 2014-02-13 | $350.00K derived: sum of 3 quarters · filed 2014-02-13 | -$571.00K 10-K · filed 2014-02-13 |
| 2012-09-30 | -$19.00K 10-Q · filed 2013-10-31 | $308.00K derived: sum of 2 quarters · filed 2013-10-31 | -$613.00K 10-Q · filed 2013-10-31 | |
| 2012-06-30 | $327.00K 10-Q · filed 2013-08-01 | $594.00K 10-Q · filed 2013-08-01 | ||
| 2012-03-31 | $267.00K 10-Q · filed 2013-05-14 | |||
| 2011-12-31 | -$205.00K 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |